52 related articles for article (PubMed ID: 37340519)
1. Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry.
Glassberg JA; Linton EA; Burson K; Hendershot T; Telfair J; Kanter J; Gordeuk VR; King AA; Melvin CL; Shah N; Hankins JS; Epié AY; Richardson LD;
Orphanet J Rare Dis; 2020 Jul; 15(1):178. PubMed ID: 32635939
[TBL] [Abstract][Full Text] [Related]
2. Stigma of sickle cell disease among Indian tribal population: A multi-centric qualitative study.
Bhat D; Babu BV; Surti SB; Ranjit M; Sarmah J; Sridevi P; Sharma Y
J Natl Med Assoc; 2023 Dec; 115(6):556-565. PubMed ID: 37845145
[TBL] [Abstract][Full Text] [Related]
3. Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry.
Mendez GG; Nocek JM; Brambilla DJ; Jacobs S; Cole O; Kanter J; Glassberg J; Saving KL; Melvin CL; Gibson RW; Treadwell M; Jackson GL; King AA; Gordeuk VR; Kroner B; Hsu LL;
BMC Health Serv Res; 2024 Mar; 24(1):291. PubMed ID: 38448911
[TBL] [Abstract][Full Text] [Related]
4. Challenges in screening for sickle cell disease among newborns from the tribal region of Palghar, Maharashtra during the COVID-19 pandemic.
Surve S; Chauhan S; Kulkarni R; Salvi N; Nadkarni A; Madkaikar M; Chaudhary K; Chavan A; Suryavanshi D; Thorat A; Kaur H
Indian J Med Res; 2023 Oct; 158(4):378-383. PubMed ID: 38006343
[TBL] [Abstract][Full Text] [Related]
5. Individualized Homeopathic and Organopathic Supportive Management of Sickle Cell Disorder: A Case Series of Six Patients from a Particularly Vulnerable Tribal Group in India.
Nambison NKM; Sharma N; Dwivedi AD; Chakravarty N
Homeopathy; 2024 Jan; ():. PubMed ID: 38290537
[TBL] [Abstract][Full Text] [Related]
6. Genetic counseling in sickle cell disease: Insights from the Indian tribal population.
Aggarwal P; Bhat D
J Community Genet; 2023 Aug; 14(4):345-353. PubMed ID: 37540483
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell disease in India: current status and progress.
Jain D; Gupta M; Madkaikar M; Jena RK; Khargekar N; Saraf SL; Krishnamurti L; Gupta K
Lancet Haematol; 2024 May; 11(5):e322-e323. PubMed ID: 38701819
[No Abstract] [Full Text] [Related]
8. Haemoglobinopathies in India: estimates of blood requirements and treatment costs for the decade 2017-2026.
Sinha S; Seth T; Colah RB; Bittles AH
J Community Genet; 2020 Jan; 11(1):39-45. PubMed ID: 30756298
[TBL] [Abstract][Full Text] [Related]
9. Let's get "real" in sickle cell disease: Real-world data and long-term patients' registries.
Minniti CP
Am J Hematol; 2024 Jun; 99(6):1019-1020. PubMed ID: 38602269
[No Abstract] [Full Text] [Related]
10. Comment on: Infertility and treatment-seeking practices among females and males with sickle cell disease in the Sickle Cell Disease Implementation Consortium registry.
Creary S; Pecker LH; Quinn GP; Nahata L
Pediatr Blood Cancer; 2023 Jun; ():e30487. PubMed ID: 37288748
[No Abstract] [Full Text] [Related]
11. Comprehensive approach to patient blood management in India.
Anne PB; Kamal M; Singh P; Bodanapu V
J Anaesthesiol Clin Pharmacol; 2023; 39(4):682-683. PubMed ID: 38269156
[No Abstract] [Full Text] [Related]
12. Mesenchymal Stem Cell Therapy for Bone Repair of Human Hip Osteonecrosis with Bilateral Match-Control Evaluation: Impact of Tissue Source, Cell Count, Disease Stage, and Volume Size on 908 Hips.
Hernigou P; Homma Y; Hernigou J; Flouzat Lachaniette CH; Rouard H; Verrier S
Cells; 2024 May; 13(9):. PubMed ID: 38727312
[TBL] [Abstract][Full Text] [Related]
13. Indian sickle cell disease registry for surveillance and patient management: Development and implementation.
Babu BV; Sharma Y; Surti SB; Bhat D; Sridevi P; Ranjit M; Sudhakar G; Sarmah J
Int J Health Plann Manage; 2023 Sep; 38(5):1483-1494. PubMed ID: 37340519
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India.
Babu BV; Sharma Y; Sridevi P; Surti SB; Ranjit M; Bhat D; Sarmah J; Sudhakar G
J Med Screen; 2023 Mar; 30(1):28-35. PubMed ID: 36036388
[TBL] [Abstract][Full Text] [Related]
15. Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study.
Babu BV; Sharma Y; Sridevi P; Surti SB; Bhat D; Ranjit M; Sudhakar G; Sarmah J
Hemoglobin; 2023 Nov; 47(6):227-236. PubMed ID: 38189147
[TBL] [Abstract][Full Text] [Related]
16. Sickle cell disease treatment and management in India: a systematic review of interventional studies.
Sridevi P; Sharma Y; Balakrishna SL; Babu BV
Trans R Soc Trop Med Hyg; 2022 Dec; 116(12):1101-1111. PubMed ID: 36227060
[TBL] [Abstract][Full Text] [Related]
17. Sickle cell anemia/sickle cell disease and pregnancy outcomes among ethnic tribes in India: an integrative mini-review.
Ganesh B; Rajakumar T; Acharya SK; Kaur H
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):4897-4904. PubMed ID: 33563075
[No Abstract] [Full Text] [Related]
18. Clinical manifestations of sickle cell disease in India: misconceptions and reality.
Jain D; Mohanty D
Curr Opin Hematol; 2018 May; 25(3):171-176. PubMed ID: 29465435
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
